Sort
8,912 grants matching “sars cov 2”
Immunologic and Clinical Sequelae after COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases
$706,210Jeffrey Andrew Sparks · Brigham And Women'S Hospital · R01 · FY2025 · AR
Prenatal to Preschool: The Impact of the Pandemic on Mothers and children, with a focus on syndemic effects on Black families
$706,010Wanjiku Felicia Mbugua Njoroge · Children'S Hosp Of Philadelphia · R01 · FY2024 · MH
Mechanisms of Gastrointestinal COVID-19
$705,849Matthew Aaron Ciorba · Washington University · R01 · FY2023 · AI
Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19
$705,648Jun Yan · University Of Louisville · R01 · FY2024 · HL
Community-based Design and Evaluation of a Conversational Agent to Promote SARS-COV2 Vaccination in Black Churches
$705,630Timothy W Bickmore · Northeastern University · R01 · FY2023 · MD
Coordination of innate and cellular mucosal immunity in SARS-CoV-2 clearance
$705,557Jacob E Kohlmeier · Emory University · R01 · FY2025 · AI
TMPRSS2 as a potential target for treatments of COVID-19 and respiratory infectious viruses in lung
$705,521Ya-Wen Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · HL
TMPRSS2 as a potential target for treatments of COVID-19 and respiratory infectious viruses in lung
$705,521Ya-Wen Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HL
The longer-term impact of prenatal exposure to SARS-CoV-2 infection and the COVID-19 vaccine on behavior, cognition, and brain functioning in the child
$705,493Anna-Sophie Rommel · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HD
Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chip
$705,488John H Connor · Boston University Medical Campus · R01 · FY2024 · HL
Impact of a SARS-CoV-2 vaccine on gut integrity, immune activation and efficacy of ART
$705,280Cristian Apetrei · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1
$704,939Priyamvada Acharya · Duke University · R01 · FY2021 · AI
COVID-19 vaccine in naive individuals and cancer patients
$704,873Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Surveillance genome sequencing to detect SARS-CoV-2 virus variants in Montana
$704,474Bruce E Bowler · University Of Montana · P20 · FY2021 · GM
Linking SARS-CoV-2 Aerosol Viability and Environmental Factors in Healthcare Settings
$704,133Kerry Kelly · University Of Utah · R01 · FY2023 · AI
Role of Uncharacterized Genes in High Pathogenic Human Coronavirus Infection
$704,107Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2016 · AI
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
$703,773David Baker · University Of Washington · R01 · FY2023 · AI
Proteomics-Driven Reverse Vaccinology for Gonorrhea
$703,672Aleksandra Elzbieta Sikora · Oregon State University · R01 · FY2022 · AI
REstoring mental health after COVID-19 through commUnity-based Psychological services in New York City (RECOUP-NY)
$703,625Brandon Alan Kohrt · George Washington University · R01 · FY2024 · MH
EpiMoRPH: A simulation environment for generating spatially-refined intervention strategies for the control of infectious disease
$703,090Joseph Mihaljevic · Northern Arizona University · R01 · FY2023 · AI
CORALE-SeroNet Project 2
$702,781Noah M Merin · Cedars-Sinai Medical Center · U54 · FY2020 · CA
The longer-term impact of prenatal exposure to SARS-CoV-2 infection and the COVID-19 vaccine on behavior, cognition, and brain functioning in the child
$702,685Anna-Sophie Rommel · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · HD
Improving Glycemia & Reducing Diabetes Distress in Adolescents & Young Adults with T1D
$702,590Lori M Laffel · Joslin Diabetes Center · R01 · FY2022 · DK
COVID-19 Mother Baby Outcomes (COMBO): brain-behavior functioning
$702,541Dani Dumitriu · Columbia University Health Sciences · R01 · FY2023 · MH
NYC Transit Workers and COVID-19: Impact of Multilevel Interventions
$702,414Robyn R.m. Gershon · New York University · R01 · FY2022 · NR